Business Daily from THE HINDU group of publications
Tuesday, Oct 30, 2007
ePaper | Mobile/PDA Version
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate Results - Pharmaceuticals
Divi Labs PAT up at Rs 91 cr

Hyderabad, Oct. 29

Divi Laboratories Ltd's profit after tax showed a three-fold increase to Rs 91 crore in the second quarter ended September 30, as against Rs 30 crore in the corresponding quarter of previous fiscal. The total income of the Hyderabad-based company grew by 48 per cent to Rs 245 crore (Rs 165 crore), according to a release. - Our Bureau

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Allsec net hit by rupee rise, increased expenditure

Firstsource net jumps 143%
Jet Q2 net at Rs 28 cr on improved load factor
United Phosphorus in red
HPCL Q2 net dips 30% on global crude price surge
Granules Q1 net at Rs 2.02 cr
Divi Labs PAT up at Rs 91 cr
JSPL Q2 up 76%
Steel sector boom propels Ferro Alloys Q2 net profit
EID Parry Q2 net down on low prices
Tata Tea dips 43% on interest costs
Sundram Fasteners Q2 net rises, to pay 45% interim
M&M Q2 net dips 26%
BHEL Q2 net zooms 91%
Agro Tech PAT up at Rs 3.7 cr in Q2
Titan Ind net profit rises 44%
Fortis Q2 health weakens with Rs 26.7 cr net loss
HDFC spreads seen improving
J&K Bank Q2 net up 30% on higher volumes
PNB net profit rises 7%; to focus on NPA recovery
Cost of deposits pulls down Oriental Bank net profit
Bank of India’s net doubles on all round growth

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line